Dr. Mendelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Hyde St
Ste 210
San Francisco, CA 94109Phone+1 415-474-7900Fax+1 415-474-7930
Education & Training
- Highland General HospitalResidency, 1985
- Highland General HospitalInternship, 1982 - 1983
- University of California San Francisco School of MedicineClass of 1982
- Antioch CollegeBA, Biology, 1977
Certifications & Licensure
- ND State Medical License 2021 - 2026
- FL State Medical License 2018 - 2026
- GA State Medical License 2018 - 2026
- HI State Medical License 2023 - 2026
- VA State Medical License 2019 - 2026
- IL State Medical License 2018 - 2026
- UT State Medical License 2020 - 2026
- American Board of Internal Medicine Internal Medicine
- Join now to see all
Awards, Honors, & Recognition
- Best Doctors USA (2009 – present), 2012
- Best Doctors San Francisco Bay Area (2010 – present), 2012
- National Science Foundation (1974), 1975
Clinical Trials
- Clinical Pharmacology of MDA [3,4-methylenedioxyamphetamine] Start of enrollment: 2009 Jan 01
- Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects Start of enrollment: 2009 Mar 01
- Study of Naltrexone for Methamphetamine Addiction Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 138 citationsBioavailability of Sublingual BuprenorphineJohn Mendelson, Robert A. Upton, E. Thomas Everhart, Peyton Jacob, Reese T. Jones
Journal of Clinical Pharmacology. 1997-01-01 - 54 citationsGabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial assessing Efficacy and Safety.Daniel E. Falk, Megan L. Ryan, Joanne B. Fertig, Eric Devine, Ricardo Cruz
Alcoholism, Clinical and Experimental Research. 2018-12-09 - 37 citationsEffects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled settingMatthew J. Baggott, Jeremy Coyle, Jennifer D. Siegrist, Kathleen J Garrison, Gantt P. Galloway
Journal of Psychopharmacology. 2016-02-15
Journal Articles
- Buprenorphine and naloxone interactions in methadone maintenance patients.Mendelson J, RT Jones, S Welm, S Batki, R Upton, Biol Psychiatry
- Determination of 4-hydroxy-3-methoxyphenylethylene glycol 4-sulfate in human urine using liquid chromatography-tandem mass spectrometry.Jacob P III, M Wilson, L Yu, J Mendelson, RT Jones, Anal Chem
- Chemical Analysis of Ecstasy Pills.Baggott, M, B Heifets, RT Jones, J Mendelson, E Sferios, J Zehnder, JAMA
- Join now to see all
Books/Book Chapters
Press Mentions
- How to Handle It When a Loved One Relapses After Getting SoberOctober 14th, 2021
- Alcohol Misuse Is Increasingly Common. So Why Aren’t More Doctors Treating It?July 13th, 2021
- Alcohol Abuse Is on the Rise, but Doctors Too Often Fail to Treat ItJuly 12th, 2021
- Join now to see all
Grant Support
- A Pilot Trial Of Naltrexone For Methamphetamine Addiction - Role Of The A118G SNPNational Institute On Drug Abuse2010
- Clinical Pharmacology Of 3,4-Methylenedioxy AmphetaminesNational Institute On Drug Abuse2004–2010
- Evaluation Of Adrenergic Pharmacotherapies For D-Ma DependenceNational Institute On Drug Abuse2008–2009
- Core--Clinical Pharmacology, MED. Selection, Method Devel., Analytic ChemisistryNational Institute On Drug Abuse2008–2009
- Methamphetamine Pharmacotherapy Development CenterNational Institute On Drug Abuse2004–2009
- MDMA Dependence And Discontinuation SyndromeNational Institute On Drug Abuse2005–2008
- Core--Clinical Pharm., MED. Selection, Method Devel.National Institute On Drug Abuse2004–2006
- Adrenergic Pharmacotherapies For D-Ma DepependenceNational Institute On Drug Abuse2004–2006
- Interactions Between Single Dose Of Oral Reserpine &Intravenous MethamphetamineNational Center For Research Resources2004–2005
- Interaction Between Serotonin Reuptake Blocker Paroxetine &MethamphetameNational Center For Research Resources2004–2005
- Clinical Pharmacology Of L-MethamphetamineNational Center For Research Resources2004
- Clinical Pharmacology Of Methamphetamine StereoisomersNational Institute On Drug Abuse1999–2003
- Pharmacokinetic Interactions:Selegiline And CocaineNational Center For Research Resources2000–2002
- Clinical Pharmacology Of Methamphetamine StereoisomersNational Center For Research Resources2000–2002
- Effects Of Continuous Cocaine Exposure On Tolerance &CravingNational Center For Research Resources1999–2002
- Relative Bioavailability Of Oral &Sublingual Buprenorphine-NaloxoneNational Center For Research Resources1999
- Psychopharmacology Of Two Oral Doses Of 3,4 Methylene DioxymethamphetamineNational Center For Research Resources1999
- Bioequivalence Of Sublingual BuprenorphineNational Center For Research Resources1997–1999
- Cocaine And Ethanol Interaction And Deuterated Cocaethylene AdministrationNational Center For Research Resources1996–1999
- Cocaine And Ethanol InteractionsNational Institute On Drug Abuse1997–1998
- Bioequivalence Of Sublingual Buprenorphine And Naloxone TabletsNational Center For Research Resources1996–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: